Targeting the PD-L1 cytoplasmic domain and its regulatory pathways to enhance cancer immunotherapy.
Saved in:
| Title: | Targeting the PD-L1 cytoplasmic domain and its regulatory pathways to enhance cancer immunotherapy. |
|---|---|
| Authors: | Chai F; Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China., Li P; Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China., Liu X; Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China., Zhou Z; Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China., Ren H; Division of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.; Collaborative Innovation Center of Biotherapy, Chengdu 610041, China. |
| Source: | Journal of molecular cell biology [J Mol Cell Biol] 2024 Apr 10; Vol. 15 (11). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 101503669 Publication Model: Print Cited Medium: Internet ISSN: 1759-4685 (Electronic) Linking ISSN: 17594685 NLM ISO Abbreviation: J Mol Cell Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
